Dr. Martens Plc receives Investment Bank Analyst Rating Update
By Johann M Cherian and Shashwat Chauhan (Reuters) -The UK's main stock indexes tumbled on Thursday in a broad-based selloff sparked by worries over a recession, while shares of...
Proactive Investors -FTSE 100 falls 92 points Mining shares lower despite BHP update Boohoo drops on sales slide 1.31pm: US jobless claims fall unexpectedly US weekly jobless...
Friday’s US jobs report is expected to show that 350,000 non-farm payrolls were added in May, supporting the Fed’s plans for further interest rate hikes to tame...
Having undergone a bit of a lean year in 2020 for IPOs, hopes were high that 2021 would be a better one for the London IPO market. This year we’ve seen more new issues come...
Dr. Martens plc is a United Kingdom-based company that designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA), Americas and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.
|Average||253.75 (+63.50% Upside)|
|No. of Analysts||8|